Ipswich Investment Management Co. Inc. Buys Shares of 1,984 Revvity, Inc. (NYSE:RVTY)

Ipswich Investment Management Co. Inc. bought a new stake in Revvity, Inc. (NYSE:RVTY) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,984 shares of the company’s stock, valued at approximately $217,000.

A number of other large investors also recently modified their holdings of RVTY. Gladius Capital Management LP grew its holdings in Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after acquiring an additional 106 shares during the period. CENTRAL TRUST Co purchased a new position in Revvity in the 4th quarter worth about $27,000. ORG Partners LLC purchased a new position in Revvity in the 4th quarter worth about $32,000. JTC Employer Solutions Trustee Ltd purchased a new position in Revvity in the 4th quarter worth about $33,000. Finally, Desjardins Global Asset Management Inc. purchased a new position in Revvity in the 4th quarter worth about $37,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Prahlad R. Singh sold 21,217 shares of Revvity stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the transaction, the insider now owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

RVTY has been the topic of a number of analyst reports. KeyCorp lifted their price target on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research note on Friday, February 2nd. Raymond James raised their price target on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Evercore ISI upgraded shares of Revvity from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $88.00 to $125.00 in a report on Thursday, January 4th. Barclays raised their price target on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, January 25th. Finally, Stifel Nicolaus raised their price target on shares of Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a report on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $118.91.

Revvity Stock Up 1.5 %

RVTY traded up $1.48 during midday trading on Friday, hitting $100.86. 731,126 shares of the company’s stock traded hands, compared to its average volume of 981,722. The company has a market cap of $12.46 billion, a PE ratio of 18.34, a price-to-earnings-growth ratio of 2.59 and a beta of 1.09. The stock’s fifty day simple moving average is $104.78 and its 200-day simple moving average is $101.64. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.07 and a quick ratio of 1.77. Revvity, Inc. has a one year low of $79.50 and a one year high of $135.67.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. Revvity had a net margin of 25.20% and a return on equity of 7.41%. The firm had revenue of $695.90 million for the quarter. As a group, equities analysts anticipate that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Friday, April 19th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Thursday, April 18th. Revvity’s dividend payout ratio is 5.09%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.